Predicting cardiac events using ventricular dyssynchrony in patients who received implantable cardioverter defibrillators: Are more treatment options required?

Yoshinaga, Keiichiro
February 2017
Journal of Nuclear Cardiology;Feb2017, Vol. 24 Issue 1, p130
Academic Journal
No abstract available.


Related Articles

  • Beneficial triple-site cardiac resynchronization in a patient supported with an intra-aortic balloon pump for end-stage heart failure. Ciszewski, Jan; Maciąg, Aleksander; Gepner, Katarzyna; Smolis-Bąk, Edyta; Sterliński, Maciej // Advances in Interventional Cardiology;2014, Vol. 10 Issue 1, p40 

    The authors present the case of a 62-year-old male patient with an implantable cardioverter-defibrillator and end-stage heart failure supported with an intra-aortic balloon pump. Implantation of a triple-site cardiac resynchronization system and complex heart failure treatment brought a...

  • Molecular imaging to predict ventricular arrhythmia in heart failure. Wollenweber, Tim; Bengel, Frank // Journal of Nuclear Cardiology;Dec2014, Vol. 21 Issue 6, p1096 

    Ventricular tachycardia (VT) is a major cause of sudden cardiac death (SCD) in patients with heart failure (HF). Left ventricular ejection fraction (LVEF) and heart failure class according to the New York Heart association (NYHA) are in most common use to identify patients that may benefit from...

  • Study Reveals Optimal Use of Cardiac Resychronization. DiMarco, John P. // Clinical Cardiology Alert;Feb2011, Vol. 30 Issue 2, p13 

    The article discusses a research paper by A.S.L. Tang and colleagues which highlights the results of the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). The study examined the effect of cardiac-resynchronization therapy (CRT) and implantable...

  • The usefulness of FDG PET/CT imaging in suspicion of LVAD infection. Tlili, Ghoufrane; Picard, François; Pinaquy, Jean-Baptiste; Domingues-Dos-Santos, Pierre; Bordenave, Laurence // Journal of Nuclear Cardiology;Aug2014, Vol. 21 Issue 4, p845 

    No abstract available.

  • Identifying non-inducible ventricular tachycardia origin utilizing defibrillator electrograms. Tschabrunn, Cory; Anter, Elad; Marchlinski, Francis // Journal of Interventional Cardiac Electrophysiology;Apr2013, Vol. 36 Issue 3, p243 

    Introduction: Developing an ablation strategy when the clinical arrhythmia cannot be induced is a challenge. Methods and results: A 72-year-old man is transferred to our facility for ventricular tachycardia (VT) storm. Endocardial and epicardial voltage mapping was normal and program stimulation...

  • Impending Sudden Cardiac Death: Treatment With Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator.  // JAMA: Journal of the American Medical Association;6/16/89, Vol. 261 Issue 23, p3394 

    Discusses the abstract of the article 'Impending Sudden Cardiac Death: Treatment With Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator,' by James D. Fonger et al., published in a 1988 issue of the 'Annals of Thoracic Surgery' journal.

  • Automatic Implantable Cardioverter Defibrillator. Manolis, Antonis S.; Rastegar, Hassan; Estes III, A. Mark // JAMA: Journal of the American Medical Association;9/8/89, Vol. 262 Issue 10, p1362 

    Discusses the development of the automatic implantable cardioverter defibrillator (ACID). Design of the apparatus to detect and terminate ventricular tachycardia (VT) or fibrillation (VF); Evolution from an investigation to a clinical tool for management of malignant ventricular arrhythmias;...

  • Sudden Cardiac Death and Implantable Cardioverter Defibrillations (lCD) and the Older Adult. Hyder, Omar; Ziv, Obad // Medicine & Health Rhode Island;Jan2010, Vol. 93 Issue 1, p27 

    The article discusses the importance of implantable cardioverter defibrillators (ICDs) in improving survival rates of sudden cardiac arrest (SCA) which results from a hemodynamically unstable heart rhythm such as ventricular fibrillation or ventricular tachycardia. It mentions that failure of...

  • The Clinical Use of Implantable Cardioverter Defibrillators: Where Are We Now? Where Should We Go? Buxton, Alfred E. // Annals of Internal Medicine;3/18/2003, Vol. 138 Issue 6, p512 

    Editorial. Assesses the progress of research on the clinical use of implantable cardioverter defibrillators (ICD). High risk for sudden and nonsudden death in patients with left ventricular dysfunction; Increased use of ICD since its introduction to clinical medicine in 1980; Need to refine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics